All
Photodynamic therapy with fractional ablation tackles actinic keratoses
February 1st 2011The use of fractional ablation and photodynamic therapy (PDT) effectively treats precancerous lesions and is well-tolerated by many patients, according to an associate professor and chief of division of dermatologic and cosmetic surgery at Mount Sinai Medical Center in New York.
EHR systems create new legal risks
February 1st 2011Recently, Dr. EMR spent a significant amount of money to add a comprehensive electronic health records system to his office. He has been told such a system will lessen his medical legal liability. Some of his physician friends suggest EHR systems will increase, rather than decrease, liability. Who is right?
Adding botanicals to skincare regimen addresses anti-aging needs
February 1st 2011Combining botanical products with prescription medications may provide patients with the best chance to slow down and reverse signs of aging skin. Not all botanical products are created equal, however. Formulation of the products can be as important as the ingredients themselves, according to a Miami cosmetic dermatologist.
Nanotechnology development spurs new skin rejuvenation products
February 1st 2011Nanotechnology is putting a new spin on the age-old notion of gold as a skin-aging treatment, as researchers with the University of Missouri pursue a new emollient and dermal filler product that boasts gold as a key ingredient.
Proper acid/alkaline levels lead to beauty - inside and out
February 1st 2011The importance of the role that diet, lifestyle and stress management plays in maintaining our general health and skin health has increasingly become a part of our conversation. As dermatologists, we can often read the internal health of the body, which is mirrored by the largest organ of the body - namely, the skin. In searching for a simple approach to inside/outside beauty, the concept of pH balance comes to mind.
FDA panel backs MRI contrast agent
January 26th 2011A Food and Drug Administration (FDA) panel has voted unanimously to recommend approval of a new contrast agent for MRI scans, despite concerns that the agent might increase the risk of nephrogenic systemic fibrosis (NSF) in patients, MedPage Today reports.
Survey suggests wide EHR buy-in
January 19th 2011Eighty-one percent of U.S. hospitals and 41 percent of office-based physicians say they intend to register for federal incentive payments for adoption and “meaningful use” of certified electronic health record (EHR) technology, InformationWeek.com reports.
Forum focus: Food allergy guidelines
January 19th 2011New guidelines for the diagnosis and treatment of food allergy, released in December, will be examined by four panelists during a two-hour forum Feb. 5 at the annual meeting of the American Academy of Dermatology (AAD) in New Orleans, the academy announced.
CDC adds Veregen as therapeutic option
January 12th 2011PharmaDerm, based here, has announced that its Veregen Ointment (sinecatechins, 15 percent), a topical medication for the treatment of external genital and perianal warts, has been added as a new therapeutic option in the 2010 Centers for Disease Control and Prevention (CDC) Sexually Transmitted Diseases Treatment Guidelines, PRNewswire reports.
FDA approves Gardasil to prevent anal cancer
January 5th 2011The Food and Drug Administration (FDA) has approved Gardasil (human papillomavirus [HPV] quadrivalent vaccine, recombinant; Merck) for the prevention of anal cancer and associated precancerous lesions due to HPV types 6, 11, 16 and 18 in people ages 9 through 26 years, PRNewswire-USNewswire reports.
2011 Medicare physician fee schedule appears positive for dermatologists
January 1st 2011The 2011 Medicare physician fee schedule published Nov. 29 by the Centers for Medicare & Medicaid Services (CMS) offers valuable insight into reimbursement for 2011. The final rule adjusts work relative value units downward for many services, but dermatology emerges as one of winners, getting a 4 percent increase overall.
Long-term topical steroid use carries risk of potential complications
January 1st 2011If the cause of a patient's dermatitis can't be completely avoided, then topical steroids are a first line of treatment in efforts to alleviate the condition. If the dermatitis is weeping, oozing or crusted, the topical steroid can be deferred a few days to allow to dermatitis to dry out somewhat.
Ustekinumab demonstrates safety, efficacy in psoriasis treatment trials
January 1st 2011New analyses from premarketing clinical trials show that ustekinumab (Stelara, Centocor Ortho Biotech) for moderate-to-severe chronic plaque psoriasis offers sustained efficacy and has a favorable safety and tolerability profile out to three years.